BAT8010
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BAT8010, covering 2026-03-30 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients [Phase 1]